Trump's Tariffs Reshaping Indian Pharma Landscape Amid US Capacity Challenges

pharmaceuticals

9 August 2026 at 6:18 pm

Trump's Tariffs Reshaping Indian Pharma Landscape Amid US Capacity Challenges

HyperFast News

Summary

US tariffs may not immediately affect Indian pharmaceutical companies, but building manufacturing capacity in the US remains expensive for them, while a Deloitte survey indicates CXOs are prioritizing specialty expansion.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.